Unhedged

Inside the traders’ black box

Market watchers have wondered for years about what really goes on inside trading firms like Citadel Securities, Susquehanna and Virtu. A recent ruling in a lawsuit brought by a medical company may provide some answers. Today on the show, host Ethan Wu asks FT reporter Joe Miller about the case, brought by Northwest Biotherapeutics. Also, we short Trader Joes and Temu.  For a free 30-day trial to the Unhedged newsletter go to: <a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank">https://www.ft.com/unhedgedoffer</a> Follow Ethan Wu (<a href="https://twitter.com/ethanywu" rel="noopener noreferrer" target="_blank">@ethanywu</a>) and Katie Martin (<a href="https://twitter.com/katie_martin_fx" rel="noopener noreferrer" target="_blank">@katie_martin_fx</a>) on X. You can email Ethan at <a href="mailto:ethan.wu@ft.com" rel="noopener noreferrer" target="_blank">ethan.wu@ft.com</a>. <a href="https://www.ft.com/content/2ed91dc8-5e13-4dba-a9bb-5004a31e671c" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.

Katie Martin, Robert Armstrong and other markets nerds at the Financial Times explain the big ideas behind what’s happening in finance right now. Every Tuesday and Thursday. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.